In conclusion, our findings provide evidence that the rs144334493 deletion allele in the promoter region of SCARB1 might increase the risk of CHD, probably by attenuating FOXA1 binding, which would lead to the under-expression of SR-BI, and further cause the reduction of reverse cholesterol efflux and increased risk of CHD. Here, SCARB1 is linked to coronary artery disorder.